Amanote Research

Amanote Research

    RegisterSign In

Targeted Therapy for Renal Cell Carcinoma

doi 10.2217/ebo.11.63
Full Text
Open PDF
Abstract

Available in full text

Date

October 1, 2011

Authors
Ronald M Bukowski
Publisher

Future Medicine Ltd


Related search

Molecular Subtyping of Metastatic Renal Cell Carcinoma: Implications for Targeted Therapy

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Efficacy of Targeted Therapy for Metastatic Renal Cell Carcinoma in the Elderly Patient Population

Clinical Genitourinary Cancer
OncologyUrology
2014English

Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs

Clinical Genitourinary Cancer
OncologyUrology
2016English

Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma

Seminars in Nephrology
Nephrology
2020English

Role of Cytokine Therapy for Renal Cell Carcinoma in the Era of Targeted Agents

Current Oncology
Oncology
2009English

Adjuvant Therapy After Nephrectomy for Renal Cell Carcinoma

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

The Role of VHL in Clear-Cell Renal Cell Carcinoma and Its Relation to Targeted Therapy

Kidney International
Nephrology
2009English

Successes and Limitations of Targeted Therapies in Renal Cell Carcinoma

Progress in Tumor Research
Cancer ResearchOncology
2014English

Targeted Therapy for the Loss of Von Hippel-Lindau in Renal Cell Carcinoma: A Novel Molecule That Induces Autophagic Cell Death

Autophagy
Cell BiologyMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy